Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia.

Abstract

BACKGROUND The outcome of approximately 20% of patients with acute lymphoblastic leukemia (ALL) remains poor because of disease recurrence. We examined whether DNA methylation of cadherin superfamily genes is a useful biomarker for ALL relapse. PROCEDURE We used Infinium Methylation 450K Arrays to assess genome-wide DNA methylation status. The methylation… (More)
DOI: 10.1002/pbc.26259

Topics

  • Presentations referencing similar topics